Kcnj12 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | KCNJ12 |
|---|---|
| Full Name | Potassium Inwardly Rectifying Channel Subfamily J Member 12 |
| Chromosomal Location | 17p11.2 |
| NCBI Gene ID | 3768 |
| OMIM | 602559 |
| Ensembl ID | ENSG00000184160 |
| UniProt ID | P48745 |
| Associated Diseases | Neurodevelopmental Disorders, Epilepsy, Autism |
KCNJ12 encodes Kir2.2, an inwardly rectifying potassium channel subunit. These channels play crucial roles in maintaining neuronal resting membrane potential and regulating excitability.
Kir2.2 channels contribute to:
KCNJ12 mutations are associated with:
While primarily neurodevelopmental, KCNJ12 has implications in:
KCNJ12 shows highest expression in:
Current therapeutic approaches:
The study of Kcnj12 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
NeuroWiki - Gene Page | Last Updated: 2026-03-04
KCNJ12-related epilepsy presents with various seizure types including:
Seizures often begin in the first year of life and may be refractory to anti-epileptic drugs.
Brain MRI in KCNJ12-related disorders is typically normal, though some patients show cerebral atrophy.
Genetic testing via targeted gene panels or whole exome sequencing identifies pathogenic KCNJ12 variants. Functional studies in Xenopus oocytes or mammalian cells can confirm variant pathogenicity.
Anti-epileptic drugs (AEDs) such as levetiracetam, valproic acid, and lamotrigine may help control seizures. The ketogenic diet has shown efficacy in some cases of ion channel-related epilepsy.
Induced pluripotent stem cell (iPSC) models derived from patient fibroblasts are being used to study KCNJ12 channel dysfunction and screen potential therapeutics.